We are live on ! Find out more
ENZN

ENZON PHARMACEUTICALS INC
ENZN

Delisted

ENZN was delisted on the 19th of May, 2016.

Back to rankings

1 hedge funds and large institutions have $13K invested in ENZON PHARMACEUTICALS INC in 2019 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

18% more capital invested

Capital invested by funds: $11K → $13K (+$2K)

0% more funds holding

Funds holding: 1 → 1 (0)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
PAM
1
Panagora Asset Management
Massachusetts
$13K – – –

ENZN Hedge Fund Activity: Q2 2019 in Review

1 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in ENZON PHARMACEUTICALS INC (ENZN) for Q2 2019, worth a combined $13K — up 18% from $11K a quarter earlier.

Fund positioning in ENZN was balanced in Q2 2019: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held ENZON PHARMACEUTICALS INC (ENZN) as of Q2 2019, unchanged from Q1 2019.
  • Funds reported $13K of ENZON PHARMACEUTICALS INC stock for Q2 2019, up 18% quarter-over-quarter.
  • 0 funds opened new ENZON PHARMACEUTICALS INC positions in Q2 2019 and 0 closed out.

Based on aggregated 13F filings for Q2 2019.